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Abstract 
Aim: To test whether an equine bone substitute block used for GBR of peri-implant 
defects renders different results from bovine block or particulated bone substitutes regarding 
the dimensions of the augmented ridge and the amount of new bone. 
Material & Methods: Mandibular premolars and molars were extracted in 8 dogs. 
After 4 months, four semi-saddle bone defects were created in each mandible and one 
titanium implant was inserted into every site. Bone augmentation by GBR was attempted 
using the following randomly assigned modalities: (1) particulated deproteinized bovine bone 
mineral (DBBM) + a collagen membrane (CM), (2) block DBBM + CM, (3) equine bone 
substitute block + CM, and (4) empty controls. After 4 months, one central and two lateral 
sections of each site were prepared. Descriptive histology and histomorphometric 
assessments were performed evaluating the augmented area (AA) within the former bone 
defect, the area of mineralized tissue (MT), non-mineralized tissue (NMT), and residual bone 
substitute (BS) within AA, the horizontal thicknesses of the augmented region (HTaugm) 
(primary outcome parameter) and of the mucosa (HTmucosa).  
Results: At the central sections AA measured 11.2 ± 3.3 mm2 for the equine block, 
9.5 ± 2.6 mm2 for DBBM block, 7.9 ± 4.8 mm2 for particulated DBBM, and 2.4 ± 2.1 mm2 for 
the empty control. All GBR groups rendered significantly higher values of AA in comparison 
to control (p ≤ 0.05). The differences in AA between GBR groups did not reach statistical 
significance (p > 0.05). The equine block rendered the highest values in HTaugm, although 
only the differences between equine block and control as well as equine block and DBBM 
block were statistically significant (p ≤ 0.05). With respect to HTmucosa, all GBR groups 
reached significantly higher values compared to control (p ≤ 0.05). The equine block 
revealed the most pronounced signs of graft degradation. 
Conclusions: GBR lead to higher ridge dimensions and thicker covering mucosa 
than empty controls. The equine block with CM resulted in the most favorable outcomes 
regarding the maintenance of ridge contour. There were no significant differences regarding 
amount of new bone between GBR treatments.  
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 Introduction 
The aim of guided bone regeneration (GBR) is to allow the placement of dental 
implants in prosthetically correct position and to resolve the peri-implant osseous defects. In 
esthetically sensitive areas GBR is also applied to increase the buccal contour of the 
alveolar ridge to achieve a pleasing appearance of the peri-implant soft tissues. 
Currently, the application of particulated xenografts in combination with resorbable 
collagen membranes is the most widely used and well documented method for the 
augmentation of peri-implant defects (Chiapasco & Zaniboni 2009, Jensen & Terheyden 
2009). There is a large body of clinical evidence documenting that survival rates of implants 
placed in conjuction with GBR, while using particulated xenografts and collagen membranes, 
are similar to those of implants placed into native bone (Benic, et al. 2009, Jung, et al. 2013, 
Zitzmann, et al. 2001, Zumstein, et al. 2012). However, particulated grafting materials in 
combination with collagen membranes are sub-optimal for the augmentation of non-
contained bone defects due to the unfavorable mechanical properties with low resistance to 
pressure and thus a risk for collapse (Mellonig, et al. 1998, Schwarz, et al. 2007, Strietzel, et 
al. 2006, Zellin, et al. 1995). In situations requiring an increase of the ridge contour, in which 
the volume stability of the region to be augmented is not provided by the adjacent bone 
walls, contour-forming augmentations by means of blocks of autogenous bone or rigid non-
resorbable membranes are considered to be the treatment of choice (Benic & Hammerle 
2014). It has, however, to be taken into account that the use of autogenous bone or non-
resorbable membranes is associated with several clinical drawbacks, e.g. pronounced long-
term resorption of the autogenous bone over time, a high risk of post-operative 
complications, and the need for removal of non-resorbable membranes (Jensen & 
Terheyden 2009, Donos et al. 2008). 
The use of blocks of bone substitute materials may represent an effective alternative 
to particulated substitutes, because they provide adequate support of the covering barrier 
membrane. Currently, there are only limited data reporting on the application of xenogenic 
and allogenic blocks in combination with collagen membranes for GBR. In a clinical study, 
blocks of deproteinized bovine bone mineral (DBBM) and collagen membranes were applied 
to 12 patients to treat horizontal bone defects before implant placement (Hammerle, et al. 
2008). After 9–10 months, in 11 of 12 patients the resulting bone volume was sufficient to 
allow implant placement in a prosthetically optimal position. It was concluded that the 
procedure was effective for horizontal ridge augmentation. These results are in agreement 
with a preclinical trial comparing autogenous bone blocks with DBBM blocks for horizontal 
ridge augmentation, in which a similar increase of ridge width was measured in both groups 
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(De Santis, et al. 2014, De Santis, et al. 2012). In fact, 3 months after GBR all sites treated 
with DBBM blocks clinically appeared suitable for implant placement.  
Collagen-containing equine-derived bone block substitute was recently investigated 
for primary ridge augmentations. Previous preclinical studies investigating different 
prototypes of this material reported good clinical handling and confirmed its biocompatibility 
(Fontana, et al. 2008, Schwarz, et al. 2010, Simion, et al. 2009). Two preclinical trials 
reported invasion of the block by connective tissue resulting in little bone formation (Fontana, 
et al. 2008, Simion, et al. 2009). In another study with a further developed prototype of the 
equine-derived scaffold, pronounced bone ingrowth and graft integration were observed, as 
well as cell-mediated degradation of the graft material (Schwarz, et al. 2010).  
In a recent in-vitro study, the volume stability of particulated and block bone 
substitutes in combination with collagen membranes for GBR of peri-implant defects was 
investigated by means of cone-beam computed tomography (CBCT) (Mir-Mari, et al. 2015). 
It was found that wound closure and flap suturing had induced a considerable displacement 
of the particulated grafting material resulting in a partial collapse of the collagen membrane. 
The displacement of grafting material was most pronounced in the coronal portion of the 
augmented site at the level of the implant shoulder. In contrast, the sites augmented with 
block bone substitutes exhibited less collapse of the membranes. The investigators 
concluded that the ability to maintain the contour of the augmented region during wound 
closure and flap suturing was significantly enhanced when using a block bone substitute as 
compared to GBR with particulated material. Based on these outcomes, an in-vivo study 
model was designed to assess the performance of two different xenogenic blocks, 4 months 
after GBR with simultaneous implant placement.  
The primary aim of the present proof-of-concept study was to test whether or not 
equine block bone substitute used for GBR of peri-implant defects renders different results 
as bovine block or particulated bone substitutes with respect to the dimensions of the 
augmented ridge. 
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Materials and methods 
This article was written in accordance with the ARRIVE (Animal research: Reporting 
of in vivo experiments) guidelines (Kilkenny et al. 2011). 
Animals 
Eight male adult beagle dogs (age 20 ± 3 months, mean weight 16.8 kg) (Isoquimen, 
Barcelona, Spain) were included in the present study. All animals exhibited a fully erupted 
permanent dentition.  
The animals were subjected to surgeries and housed in the Animal Experimentation 
Service Facility at the Veterinary Hospital Rof Codina, Lugo, Spain. Before the initiation of 
the trial in October 2011, the study protocol was approved by the Ethical Committee Rof 
Codina Foundation. All the procedures were performed according to Spanish and European 
Union regulations about care and use of research animals. The dogs were monitored daily 
during the entire study procedure by a veterinarian accredited in laboratory animal science. 
The animals were housed in a group kennel with indoor and outdoor areas. The indoor area 
presented a controlled temperature of 20-22 °C with natural light and air renewal. During the 
entire study period, the dogs received soft-food diet and water ad libitum. The study started 
after a 3-week long adaption period for the animals. 
 
Study design and randomization 
This study was designed as a randomized controlled trial with intra-subject control for 
the comparison of four treatment procedures. The study was performed in two surgical 
phases including (1) tooth extraction and (2) implant placement with simultaneous GBR of 
acute-type peri-implant bone defects (four defects per animal). 
The experimental sites were randomly allocated to one of the four treatment 
procedures according to a computer-generated randomization list. Allocation to the treatment 
was concealed by means of sealed envelopes until the time of the GBR procedure. 
 
Surgical procedures 
The investigators participating in the study were experienced in implant placement 
and bone regeneration procedures. 
All surgical procedures were performed under general anesthesia of the animals. The 
animals were premedicated with medetomidine (20 µg/kg/i.m., Esteve, Barcelona, Spain) 
and morphine (0.4 mg/kg/i.m., Morfina Braun 2%, B. Braun Medical, Barcelona, Spain). The 
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anesthesia was initiated by propofol (2 mg/kg/i.v., Propovet, Abbott Laboratories, Kent, UK), 
and maintained by inhalation of an O2 and 2.5-4% isoflurane mixture (Isobavet, Schering-
Plough, Madrid, Spain). A local anesthesia composed of lidocaine and adrenalin (Anesvet®, 
Ovejero, León, Spain) was used to reduce peri-operative pain and bleeding. During 
anesthesia, the animals were monitored by a veterinarian, applying electrocardiography, 
capnography, pulsioxymetry and blood pressure measurements. After the surgical 
intervention, atipamezol (50 µg/kg/i.m., Esteve, Barcelona, Spain) was administered to revert 
the effects of the medetomidine. 
After the surgeries, pain was controlled with morphine (0.3 mg/kg/i.m.) for 24 h and, 
subsequently, with meloxicam (0.1 mg/kg/s.i.d/p.o., Metacam, Boehringer Ingelheim, 
Barcelona, Spain) for 3 days. Antibiotics (amoxicillin 22 mg/kg/ s.i.d./s.c., Amoxoil retard, 
Syva, Leon, Spain) were administrated for 7 days. 
During the first two post-operative weeks, the oral mucosa and the teeth were 
disinfected three times a week by using gauzes soaked in a 0.12% chlorhexidine solution 
(Perio-Aid Tratamiento®, Dentaid, Barcelona, Spain). Subsequently, a tooth-brush and a 
0.2% chlorhexidine gel (Chlorhexidine Bioadhesive Gel, Lacer, Barcelona, Spain) were used 
for plaque control. 
 
Surgery 1 (tooth extraction) 
The mandibular premolars P2, P3, P4 and the molars M1 and M2 were bilaterally 
hemi-sectioned with fissure burs and extracted by using dental elevators and forceps. 
Wound closure was obtained by means of resorbable sutures (Vicryl® 5-0, Ethicon, Issy Les 
Moulineaux Cedex, France). 
 
Surgery 2 (defect preparation, implant placement and GBR) 
Preparation of defects, implant placement and GBR of peri-implant bone defects 
were performed 4 months after tooth extraction. Following a 25 mm-long mid-crestal incision 
and a vertical releasing incision at the disto-buccal aspect of the first premolar, the 
mucoperiostal flaps were elevated. The edentulous portion of the ridge was flattened to 
obtain a bucco-oral ridge width of 8 mm. On each side of the mandible, two standardized 
semi-saddle-type bone defects including removal of the buccal aspect of the alveolar ridge 
were prepared at a distance of 4 mm from each other. The defects measured 10 mm mesio-
distally, 6 mm bucco-orally and 5 mm apico-coronally (Fig. 1). All the osteotomy procedures 
were performed under irrigation with sterile 0.9% saline. 
 7 
One 8 mm-long and 4 mm-diameter titanium implant (OsseoSpeed™ S, ASTRA 
TECH Implant System, DENTSPLY Implants, Mannheim, Germany) was inserted in each 
defect site obtaining primary stability (Fig. 1). The implants were placed with the central axis 
at 5 mm from the mesial and the distal walls of the defect. The apico-coronal position of the 
implant shoulder coincided with the level of the alveolar crest at the lingual aspect. The 
distance between the exposed implant surface and the buccal margin of the apical bone wall 
measured 3 mm (Fig. 1). Titanium closure screws (ASTRA TECH Implant System, 
DENTSPLY Implants, Mannheim, Germany) were placed on the implants. 
The defects were randomly allocated to receive one of the following treatments (Fig. 
2): 
• Bovine granulate: particulated DBBM (Bio-Oss® granules 0.25-1 mm, 
Geistlich Pharma AG, Wolhusen, Switzerland) + a non-cross-linked native 
collagen membrane (CM) (Bio-Gide®, Geistlich Pharma AG) 
• Bovine block: DBBM cancellous block: 10 mm x 10 mm x 20 mm (Bio-Oss® 
spongiosa block, Geistlich Pharma AG) + CM 
• Equine block: collagen-containing cancellous equine-derived bone block: 5 
mm x 10 mm x 10 mm (Geistlich Pharma AG) + CM 
• Control: empty (no biomaterials) 
The bovine and the equine blocks were individually shaped and adapted to fit the 
defects by using cylindrical carbide drills. Prior to the application, all bone substitutes were 
hydrated with sterile saline solution. At the sites allocated for GBR, the defects were filled 
with bone substitute without surpassing the contour of the alveolar ridge. CM was applied to 
cover the bone substitute and overlap the walls of the defect by at least 2 mm (Fig. 2). No 
screws or pins for stabilization of blocks and membranes were used. Bleeding was allowed 
to form a blood clot in the control sites, where no further treatment was applied. 
The periosteum of the buccal flap was relieved along its base and primary wound 
closure was accomplished by placing horizontal mattress and interrupted sutures made of 
ePTFE (Gore-Tex® sutures 5-0, W.L. Gore & Associates Inc., Flagstaff, AZ, USA). The 
sutures were removed after 2 weeks. 
 
Retrieval of specimens 
Four months after implant placement and GBR, the animals were sedated with 
medetomidine (30 µg/kg/i.m., Esteve, Barcelona, Spain) and subsequently sacrificed with an 
overdose of sodium pentobarbital (40–60 mg/kg/i.v., Dolethal, Vetoquinol, France). The 
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mandibles were dissected and the experimental specimens were retrieved with intact soft 
tissues. 
 
 
Histological preparation 
Fixation of the specimens was performed in buffered formalin at a temperature of 4ºC 
for 1 week. The specimens were dehydrated using ethanol solutions of increasing 
concentrations and subsequently embedded in a glycol methacrylate resin (Technovit 7200 
VLC, Heraus-Kulzer GmbH, Werheim, Germany) (Donath & Breuner, 1982).  
Three bucco-oral sections were prepared from each implant site: (1) a central section 
through the long axis of the implant, (2) a lateral section 1.5 mm mesially to the implant, and 
(3) a lateral section 1.5 mm distally to the implant. 
Tissue blocks were cut into 200 µm-thick sections using a diamond band saw (Exakt 
Apparatebau, Norderstedt, Germany). The sections were ground and polished to a thickness 
of 40 µm (Exakt Apparatebau, Norderstedt, Germany). All the sections were stained with 
toluidine blue (Schenk, et al. 1984). 
 
Histological and histomorphometrical analyses 
Histological and histomorphometrical analyses were performed by one experienced 
investigator masked to the specific experimental conditions. For image capturing, a light 
microscope (BX51, Olympus, Tokyo, Japan) connected with a digital color camera (DP71, 
Olympus, Tokyo, Japan) was used. 
A semi-quantitative histological evaluation was performed according to the ISO 
10993-6 standards. The following grading scale was used: 0 = absent, 1 = slight, 2 = 
moderate, 3 = marked, and 4 = severe. 
For histomorphometrical analysis, digital images were evaluated using two PC-based 
image analysis softwares (Cell-sens 1.5, Olympus Corporation, Japan and Microimage 4.0, 
Media Cybernetics, Silver Springs, MD, USA). 
For each central section, the following variables were assessed:  
• the augmented area (AA) (mm2) within the former bone defect  
• the area of mineralized tissue (MT) (mm2), non-mineralized tissue (NMT) 
(mm2), and residual bone substitute (BS) (mm2) within AA 
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• the horizontal thickness of the augmented region measured in a direction 
perpendicular to the implant axis at the level of the implant shoulder (HTaugm 
0mm) (primary outcome variable) and at 1 mm, 2 mm, and 3 mm apical to the 
implant shoulder (HTaugm 1mm - HTaugm 3mm) (mm) 
• the horizontal thickness of the mucosa at the level of the implant shoulder 
(HTmucosa 0mm)  and at 1 mm apical to the implant shoulder (HTmucosa 1mm) (mm) 
• the horizontal thickness of the augmented region + mucosa at the level of the 
implant shoulder (HTtotal 0mm) and at 1 mm apical to the implant shoulder 
(HTtotal 1mm) (mm) 
For each lateral section, the following variables were assessed:  
• AA, MT, NMT, BS 
• the surface fraction of bone substitute in contact with newly formed 
mineralized tissue (BS-MTsurface) (%) 
 
Statistical analysis  
The animal was chosen as the unit for the statistical analysis. The primary outcome 
parameter was HTaugm 0mm. The values for mesial and distal lateral sections were averaged to 
one value per implant site. The data were reported by using means, standard deviations 
(SD), ranges, 95% confidence intervals (CI), medians, and interquartile ranges (IQR) (SPSS 
version 18.0, SPSS Inc., Chicago, IL, USA). The Wilcoxon’s signed rank test was applied to 
detect differences between the treatments. The results of tests with p-values ≤ 0.05 were 
considered statistically significant. Due to the exploratory nature of this study, no sample size 
calculation and no correction for multiple testing were performed. 
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Results 
Clinical findings 
Considerable differences regarding the clinical manageability were observed 
between bovine and equine blocks. While bovine blocks frequently fractured during trimming 
and application into the bone defect, the equine blocks appeared mechanically stable, 
permitting effective shaping. Moreover, the slight elasticity of the equine material allowed 
“press-fit” adaptation and mechanical anchorage within the box-shaped defects. 
A post-operative mucosal dehiscence with implant loss was observed only in one site 
augmented with a bovine block. A total of 8 bovine granulate, 7 bovine block, 8 equine block 
and 8 control sites were available for the histological and the histomorphometrical analyses. 
 
Histological findings 
The results of the semi-quantitative analysis are presented in Tables A1 and A2 
(Appendix). 
All the implants were osseointegrated. In the majority of the sites the most coronal 
bone-to-implant-contact at the lingual aspect of the implant was located coronally to the 
implant shoulder. 
In the empty control sites re-establishment of the ridge contour was less effective as 
compared with all other treatment groups (Fig. 3 and 4). This resulted in the collapse of the 
mucosa that was particularly pronounced at the central sections. DBBM particles were 
disseminated in the apical and oral portions of the augmented regions. A partial 
displacement of granules apically to the former defect was detected in 4/8 (50%) cases at 
central sections and in at 3/8 (38%) cases at lateral sections. Bovine and equine blocks 
showed a similar looking interconnected trabecular system. Nonetheless, differences were 
found regarding the mechanical stability of block materials. Microfractures of the trabeculae 
of the bovine block were detected in 6/7 (86%) cases at central sections and in 4/7 (57%) 
cases at lateral sections (Fig. 5). These cracks were colonized by connective tissue cells. In 
one case out of seven (14%), apical displacement of fragments of bovine block was 
observed at central and at lateral sections. No fractures or displacement of the grafting 
material were detected at the specimens treated with the equine block.  
The bovine granules revealed the lowest amount of degradation signs followed by the 
bovine block. A small number of inflammatory cells were detected around the bovine-derived 
materials. Bovine blocks were surrounded by a small number of macrophages and 
osteoclasts. In contrast, the equine block often showed a marked biodegradation of the 
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trabeculae that were surrounded by a significant amount of macrophages (Fig. 6). Moreover, 
the equine-derived material was frequently associated with the presence of foci of plasmatic 
and lymphocytic-like cells. In the cases without pronounced signs of degradation, the equine 
block was well kept in place and the ridge contour well preserved. In two cases, equine 
blocks showed advanced resorption associated with a reduced ridge width. 
For all treatment groups, the amount of new bone was considerably higher at the 
lateral sections as compared to the central sections. In the majority of the central sections, 
only a minor portion of the initially exposed implant surface was in contact with new bone. 
Considerable differences were observed regarding the regenerative potential of the bone 
substitutes. Particles of bovine granulate were frequently in contact with trabeculae of woven 
bone and with highly vascularized dense connective tissue. In general, equine and bovine 
blocks revealed poor bone ingrowth that originated from open marrow spaces and periosteal 
region (Fig. 7). The block materials were mostly invaded with a moderately vascularized 
dense fibrous tissue. Two animals showed a high regenerative potential exhibiting an almost 
complete osseous organization of the former bone defects and a pronounced resorption of 
the equine block (Fig. 8).  
 
Histomorphometrical results                            
Central sections 
AA amounted to 11.2 ± 3.3 mm2 (SD) for the equine block, 9.5 ± 2.6 mm2 (SD) for the 
bovine block, 7.9 ± 4.8 mm2 (SD) for the bovine granulate, and 2.4 ± 2.1 mm2 (SD) for the 
empty control (Tables 1a, 1b). All GBR groups rendered significantly higher values of AA in 
comparison to empty controls (equine block: p = 0.016; bovine block: p = 0.016; bovine 
granulate: p = 0.039). The differences in AA between the GBR groups did not reach 
statistical significance (p > 0.05). 
There were no statistically significant differences in MT and BS between the 
treatment groups (p > 0.05) (Tables 1a, 1b). 
With regards to the horizontal thickness of the augmented region, HTaugm 0mm - HTaugm 3mm 
reached the highest mean values for the equine block (Tables 1a, 1b). The differences in 
HTaugm between the equine block and the control were statistically significant (HTaugm 0mm: p = 
0.016, HTaugm 1mm: p = 0.016, HTaugm 2mm: p = 0.008). In terms of horizontal thickness of the 
mucosa, HTmucosa 0mm amounted to 1.8 ± 1.0 mm (SD) for the equine block, 1.7 ± 0.9 mm (SD) 
for the bovine block, 1.6 ± 0.8 mm for the bovine granulate, and 0.9 ± 0.6 mm for the control. 
All GBR groups reached significantly higher values of HTmucosa 0mm compared to control 
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(equine block: p = 0.047; bovine block: p = 0.047; bovine granulate: p = 0.016) (Tables 1a, 
1b). 
When assessing the total horizontal thickness of the augmented region + mucosa, 
HTtotal 0mm and HTtotal 1mm reached the highest mean values for the equine block followed by 
the bovine block, the bovine granulate and the control (Tables 1a, 1b). All GBR groups 
revealed significantly higher values of HTtotal 0mm in comparison to the empty control (p = 
0.016). The values of HTtotal 1mm were significantly higher for equine and bovine blocks as 
compared to the control (equine block: p = 0.031; bovine block: p = 0.016).  
 
Lateral sections 
AA measured 19.9 ± 5.3 mm2 (SD) for the equine block, 19.5 ± 3.0 mm2 (SD) for the 
bovine block, 17.8 ± 5.6 mm2 (SD) for the bovine granulate and 11.9 ± 2.3 mm2 (SD) for the 
control (Tables 2a, 2b). Equine and bovine blocks rendered statistically higher values of AA 
as compared to the control (equine block: p = 0.023; bovine block: p = 0.016). The difference 
in AA between the bovine granulate and the control did not reach statistical significance (p = 
0.078). 
MT amounted to 6.0 ± 5.5 mm2 (SD) for the equine block, 4.3 ± 3.8 mm2 (SD) for the 
bovine block, 5.4 ± 2.8 mm2 (SD) for the bovine granulate and 8.9 ± 2.5 mm2 (SD) for the 
control (Tables 2a, 2b). The values of MT for the bovine block and the bovine granulate were 
significantly lower in comparison to the empty control (p = 0.016). 
BS measured 2.1 ± 1.6 mm2 (SD) in the equine block group, 3.5 ± 1.1 mm2 (SD) in 
the bovine block group and 3.7 ± 1.5 mm2 (SD) in the bovine granulate group (Tables 2a, 
2b). The differences between the equine block and the bovine materials reached statistical 
significance (equine block vs. bovine block: p = 0.016; equine block vs. bovine granulate: p = 
0.039).  
BS-MTsurface measured 24.4 ± 23.0 % (SD) for the bovine granulate and 16.3 ± 21.4 
% (SD) for the bovine block (Tables 2a, 2b). The difference between the two groups was 
statistically significant (p = 0.016). For the equine block, the corresponding value was 18.9 ± 
31.6 % (SD). 
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Discussion 
The present study demonstrated a significant benefit of performing GBR over empty 
defects to restore deficient bone contour at peri-implant defects. When comparing the GBR 
groups, the equine bone block substitute in combination with CM reached the highest mean 
values in ridge dimensions, followed by DBBM block and DBBM granulate in combination 
with CM. The width of the augmented region at the level of the implant shoulder reached in 
average 0.8 mm for DBBM granulate and 1.8 mm for the equine block. However, the 
differences in ridge dimensions between the GBR groups did generally not reach statistical 
significance. 
The differences in the augmented ridge dimension between the GBR groups can be 
explained by different mechanical properties of the grafting materials. Intra-operatively, the 
equine block was not prone to fractures, thereby permitting “press-fit” adaptation and 
mechanical anchorage within the box-shaped defects. Moreover, no fractures or 
displacements of this material were observed in the histological samples. In contrast, 
fractures of DBBM block and displacements of DBBM granules in the apical direction were 
often observed. The reason of this outcome was probably due to the forces applied on the 
alveolar ridge by dogs, which could not be controlled beyond feeding with soft diet. 
The volume stability of different materials for GBR during blinded suturing of mucosal 
flaps was investigated in a recent in-vitro examination (Mir-Mari, et al. 2015). In this study, 
the stability of the following material combinations were tested by means of CBCT: (1) 
particulated DBBM + CM, (2) particulated DBBM + CM + fixation pins, and (3) DBBM block  
+ CM. The investigators found that wound closure always induced a displacement of the 
bone substitute, resulting in a partial collapse of CM in the coronal portion of the augmented 
site. First, the initial stability of the bone substitute and CM was enhanced by application of 
fixation pins. Secondly, the block bone substitute in combination with CM performed 
significantly better than the particulated material covered with CM. 
The stability of horizontally augmented ridge during healing was investigated in a 
previous animal study (Thoma, et al. 2012). The standardized acute defects were 
augmented with particulated DBBM, alone or in combination with a membrane. For control 
purposes, one defect at each animal remained untreated. The histological assessment was 
performed at baseline immediately after surgery, at 4 weeks and at 16 weeks post-
operatively. It was found that sites augmented with bone substitutes performed significantly 
better compared to the empty control with respect to the ridge contour. In the majority of the 
augmented sites, a continuous reduction in the dimension of the augmented ridge was found 
between the three time-points, with the most pronounced reduction between baseline and 4 
weeks. Owing to the low biodegradation rate of DBBM, a considerable resorption of the bone 
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substitute during this relatively short period should be excluded. The dimensional reduction 
of the augmented ridges could, therefore, rather be explained by the displacement of DBBM 
particles during the healing period. In the same study, it was observed that the application of 
polyethylene glycol membrane over DBBM granules considerably decreased the amount of 
post-operative ridge reduction compared to the group with DBBM granules alone (Thoma, et 
al. 2012). This finding can be explained by the mechanical containment of the grafting 
material by the membrane. However, the results of this study cannot be directly compared 
with the data of the present trial due to different types of membrane used for GBR. A 
comparison of particulated and block DBBM for horizontal augmentation of chronic-type 
bone defects was performed in another preclinical study (Schwarz, et al. 2008). In this trial 
the bone substitute and CM were used alone or with an addition of growth factors. After 3 
and 8 weeks, samples were prepared for histological analysis. When assessing the width of 
the augmented ridge, block of DBBM stabilized by titanium screws appeared to perform 
better in comparison to particulated DBBM. The results of these studies are in accordance 
with the findings of the present investigation. 
With respect to the amount of new bone within the augmented area there were no 
significant differences between the bone substitutes. As far as the surface fraction of bone 
substitute in contact with new bone, bovine granulate reached higher values compared to the 
block materials. The difference between DBBM granulate and DBBM block reached 
statistical significance, indicating a superior osteoconductivity of particulated material in 
comparison to the block. The difference in the rate of bone ingrowth is presumably due to the 
differences in the macrostructure, with particulated material possibly permitting ingrowth of 
blood vessels and new bone. In general, bone ingrowth within the equine and the bovine 
blocks was limited to the peripheral areas in contact with cancellous bone. The block 
materials were mostly invaded by moderately vascularized fibrous tissue. 
The equine block showed the most pronounced signs of biodegradation. 
Nevertheless, in the majority of specimens the equine block was kept in place and the ridge 
contour was well preserved. In the central sections, the sites treated with equine and bovine 
blocks presented similar amount of remaining bone substitute. In the lateral sections, the 
same parameter reached significantly lower values for equine block as compared to DBBM 
block and DBBM granulate. Macrophages, plasmatic- and lymphocytic-like cells were 
generally identified surrounding trabeculae of the equine block. The presence of a larger 
number of inflammmatory cells demonstrates the higher antigenic capacity of the collagen-
containing equine block compared to DBBM. It is worth mentioning that two dogs presented 
a considerably higher regenerative potential in comparison with the remaining animals. The 
corresponding specimens revealed an almost complete degradation of the equine block and 
substitution by new bone.  
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In an earlier study, the equine block and the DBBM block were used for horizontal 
ridge augmentation of acute bone defects in combination with stabilization screws and CM 
(Schwarz, et al. 2010). After 12 weeks, the trabecular architecture of the equine block 
appeared to be considerably looser when compared with the DBBM specimens. A 
histopathological difference between the materials was observed with respect to the 
presence of osteoclasts and multinucleated giant cells, which appeared to be moderately 
increased in the equine block group and directly involved in the degradation of this material. 
These findings are in agreement with the results of the semi-quantitative analysis in the 
present study. The observations from this study were corroborated by the 
histomorphometrical analysis, which revealed significantly less remaining bone substitute for 
the equine block compared to DBBM block (Schwarz, et al. 2010). Simultaneously, the 
equine block featured an increased extent of bone ingrowth compared to the bovine block. 
The difference between the remaining amounts of bovine and equine block was much more 
pronounced than the difference found in the present trial. In fact, in the previous study the 
amount of the remaining equine block after 3 months appeared to be lower compared to the 
amount of the remaining equine block after 4 months in the present trial. The lower 
degradation rate of the equine block tested in the present study can partially explain the 
increased ability to maintain the contour of the augmented ridge. An earlier preclinical trial 
used prototype of the equine block alone or in combination with CM for vertical ridge 
augmentation (Simion, et al. 2009). In this study, only an initial resorption of the grafting 
material with invasion of connective tissue and limited bone formation were observed after 5 
months. 
Poor osteoconductive propriety and almost no degradation of the DBBM block 
observed in the present study are in agreement with the findings of several previous studies 
(Araujo, et al. 2002, De Santis, et al. 2014, De Santis, et al. 2012, Schmitt, et al. 2013, 
Schwarz, et al. 2010). In these trials using DBBM blocks for onlay grafting alone or in 
combination with membranes, very little newly formed bone was encountered within the 
grafts, which were mainly invaded by connective tissue. Whether DBBM is bioresorbable still 
remains controversial (Berglundh & Lindhe 1997, Fugazzotto 2003, Mordenfeld, et al. 2010). 
The presence of cells with osteoclastic characteristics was interpreted as a sign of ongoing 
resorption of DBBM (Piattelli, et al. 1999). A recent clinical trial including 20 patients found 
DBBM particles unchanged and integrated in the bone 11 years after sinus floor 
augmentation (Mordenfeld, et al. 2010). 
 A model of an acute-type semi-saddle defect was used to compare the performance 
of different bone substitutes for GBR of peri-implant bone defects. This type of defect has 
been applied in several previous studies for the investigation of GBR with or without 
simultaneous placement of implants (Jung, et al. 2011, Schwarz, et al. 2010, Thoma, et al. 
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2012). Other studies used a chronic-type bone defect, which is considered to simulate better 
the clinical reality (Schwarz, et al. 2008). However, this type of defect was reported to vary in 
size at the time-point of the GBR surgery (von Arx, et al. 2001). The chronification of the 
defects was, therefore, omitted to standardize the initial defect dimension in all groups, 
aiming at reproducible surgical procedure and histomorphometrical analysis. Acute bone 
defects have a higher potential for regeneration as a biologic reaction to the surgical trauma 
(Schenk 1992). Nevertheless, the experimental model used in the present study can be 
considered challenging for bone regeneration, which is demonstrated by the poor 
spontaneous regeneration in the empty control. This finding may be explained by the large 
defect size and the fact that the implant shielded the cancellous bone in the central region of 
the defect. Consequently, for all treatment groups the amount of mineralized tissue was 
lower at the central sections in comparison to the lateral ones. Possibly, a longer healing 
time would have been needed to allow more bone ingrowth into the central region of the 
defect. The contour of the augmented ridge was better maintained at the lateral sections in 
comparison to the central ones. This can be explained by the proximity of the lateral bone 
walls, which partially supported the barrier membrane. In other words, despite the three-wall 
morphology the volume of the large bone defect was not well contained by the adjacent bone 
walls. Therefore, the lateral sections should be considered as more adequate for the 
evaluation of biodegradation and osteoconductivity, whereas the volume stability of 
biomaterials should rather be assessed at the central sections. Moreover, information 
regarding dynamics of biological processes (e.g. graft degradation) might be extrapolated 
from the comparison between the lateral and the central sections, as these samples 
potentially represent different stages of the healing process. 
One of the main clinical aims of bone augmentation procedures is to generate a 
sufficient volume of hard tissue to support the mucosa and optimize the appearance of peri-
implant soft tissue. The fact that the equine bone block substitute in combination with CM 
performed well regarding the maintenance of the augmented ridge contour is a clinically 
relevant aspect. The use of bone block substitutes for bone augmentation has the potential 
to enhance the performance of GBR with respect to maintenance of the augmented ridge 
contour and to reduce the need of non-resorbable membranes.  
The small sample size and the statistical analysis without the correction for multiple 
testing are limitations, which have to be taken into account when interpreting the findings of 
the present study. Nevertheless, this proof-of-concept trial provides valuable information on 
the volume stability and the tissue integration of particulated and block bone substitutes for 
GBR. Further investigations in humans are needed to examine the clinical implications of the 
findings of the present study. Future clinical research should assess and monitor the long-
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term stability of the augmented ridge. The influence of augmentation procedures on implant 
survival and success rate needs to be determined. 
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Conclusion 
Within the limitations of the present study, it can be concluded that for augmentation 
of peri-implant bone defects: 
• The application of bone substitutes and collagen membranes performed 
significantly better compared to empty controls with respect to the volume of 
the augmented ridge and the thickness of the overlying mucosa. 
• The equine block resulted in the most favorable outcomes regarding the width 
of the augmented ridge 
• In terms of new bone formation, there were no differences between the bone 
substitutes. In the lateral regions of the defect, the empty controls resulted in 
the most favorable outcomes regarding the amount of new bone. 
• The equine block revealed more pronounced signs of degradation compared 
to the bovine-derived materials. 
 
 
 19 
 Acknowledgements 
The investigators gratefully acknowledge Gisela Müller (Clinic of Fixed and 
Removable Prosthodontics and Dental Material Science, Center of Dental Medicine, 
University of Zurich, Switzerland) and Dr. Ela Bingel-Erlenemeyer (Geistlich Pharma AG, 
Wolhusen, Switzerland) for assistance in preparing the manuscript, and Dr. Michael Mayer 
(Consult AG, Bern Switzerland) for assistance in analyzing the data. This study was 
supported by the Clinic of Fixed and Removable Prosthodontics and Dental Material 
Science, Center of Dental Medicine, University of Zurich, Switzerland and by a research 
grant from Geistlich Pharma AG, Wolhusen, Switzerland. 
 
 
 
 
 
 
 
 
 20 
Table legend 
Table 1a. Results of the histomorphometrical analysis of the central sections 
Table 1b. Results of the statistical test for comparisons between groups at the central 
sections 
Table 2a. Results of the histomorphometrical analysis of the lateral sections 
Table 2b. Results of the statistical test for comparisons between groups at the lateral 
sections 
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Figure legend 
Figure 1. (a) Buccal and (b) occlusal views of the bone defects prior to GBR 
Figure 2. (a, b) Empty control (left) and GBR with equine-derived bone block in 
combination with a collagen membrane (right). (c, d) GBR procedures with particulated (left) 
and block (right) DBBM in combination with a collagen membrane. 
Figure 3. Histological views at the central sections (original magnification x 10): (a) 
equine bone block with collagen membrane (CM), (b) DBBM block with CM, (c) particulated 
DBBM with CM, and (d) empty control. 
Figure 4. Histological views at the lateral sections (original magnification x 10): (a) 
equine bone block with collagen membrane (CM), (b) DBBM block with CM, (c) particulated 
DBBM with CM, and (d) empty control. 
Figure 5. Microfractures of the trabeculae of bovine block (original magnification x 
100). 
Figure 6. Biodegradation of the equine block scaffold that is surrounded by a 
significant amount of macrophages (original magnification x 200). 
Figure 7. The ingrowth of bone in the equine block mainly originated from open 
marrow spaces (original magnification x 10). 
Figure 8. Advanced osseous integration and pronounced resorption of an equine 
block specimen (original magnification x 10). 
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Appendix 
Table A1. Results of the semi-quantitative histological analysis of the central sections 
Table A2. Results of the semi-quantitative histological analysis of the lateral sections 
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Parametar Unit Treatment	  modality
Equine	  block	  	  (EB)	  
(n=8)
Bovine	  block	  (BB)	  
(n=7)
Bovine	  granules	  (BG)	  
(n=8)
Empty	  control	  (C)	  
(n=8)
Mean	  ±	  SD	  	  	  	  	  	  	  	  	  	  	  	  	  
(Q1,	  median,	  Q3)
AA mm2 11.2	  ±	  3.3 9.5	  ±	  2.6 7.9	  ±	  4.8 2.4	  ±	  2.1
(8.8,	  11.5,	  13.9) (8.1,	  9.6,	  11.6) (3.8,	  8.8,	  11.0) (1.2,	  1.9,	  2.5)
MT mm2 1.8	  ±	  2.6 1.2	  ±	  1.6 2.2	  ±	  1.5 1.9	  ±	  1.8
(0.3,	  0.4,	  2.2) (0.2,	  0.3,	  2.0) (1.0,	  2.3,	  2.9) (0.9,	  1.5,	  1.9)
NMT mm2 7.6	  ±	  4.1 6.6	  ±	  2.7 4.6	  ±	  3.4 0.4	  ±	  0.3
(6.0,	  8.8,	  10.7) (6.2,	  6.6,	  8.2) (2.3,	  4.5,	  6.9)	   (0.3,	  0.4,	  0.5)
BS mm2 1.8	  ±	  1.2 1.7	  ±	  0.8 1.1	  ±	  0.8 -­‐
(0.8,	  2.3,	  2.7) (1.4,	  1.9,	  2.2) (0.6,	  1.1,	  1.6)
HTaugm	  0mm mm 1.7	  ±	  1.1 0.6	  ±	  1.0 0.8	  ±	  1.1 0	  ±	  0
(0.9,	  1.7,	  2.6) (0.0,	  0.0,	  0.9) (0.0,	  0.0,	  1.7) (0.0,	  0.0,	  0.0)
HTaugm	  1mm mm 2.2	  ±	  1.1 1.6	  ±	  0.9 1.4	  ±	  1.4 0	  ±	  0
(1.8,	  2.6,	  3.1) (1.4,	  1.6,	  2.0) (0.0,	  1.5,	  2.3) (0.0,	  0.0,	  0.0)
HTaugm	  2mm mm 2.6	  ±	  1.0 2.2	  ±	  1.1 1.9	  ±	  1.6 0.1	  ±	  0.2
(2.1,	  2.9,	  3.3) (1.9,	  2.6,	  2.8) (0.7,	  2.1,	  2.8) (0.0,	  0.0,	  0.0)
HTaugm	  3mm mm 2.8	  ±	  0.8 2.5	  ±	  0.6 2.2	  ±	  1.8 0.5	  ±	  0.7
(2.6,	  3.0,	  3.2) (2.2,	  2.6,	  2.9) (1.1,	  2.3,	  3.1) (0.0,	  0.0,	  1.0)
HTmucosa	  0mm mm 1.8	  ±	  1.0 1.7	  ±	  0.9 1.6	  ±	  0.8 0.9	  ±	  0.6
(1.0,	  1.7,	  2.2) (1.2,	  1.4,	  2.3) (1.0,	  1.7,	  2.1) (0.4,	  0.8,	  1.2)
HTmucosa	  1mm mm 1.3	  ±	  0.6 1.6	  ±	  0.5 1.4	  ±	  0.3 1.3	  ±	  0.5
(1.0,	  1.3,	  1.8) (1.3,	  1.8,	  1.9) (1.3,	  1.5,	  1.6) (0.9,	  1.1,	  1.7)
HTtotal	  0mm mm 3.3	  ±	  1.2 2.3	  ±	  0.9 2.5	  ±	  1.4 0.9	  ±	  0.6
(2.3,	  3.4,	  4.2) (1.8,	  2.6,	  3.0) (1.7,	  2.6,	  3.3) (0.4,	  0.8,	  1.2)
HTtotal	  1mm mm 3.3	  ±	  1.0 3.2	  ±	  0.8 2.8	  ±	  1.4 1.3	  ±	  0.5
(2.7,	  3.6,	  3.9) (2.8,	  3.4,	  3.6) (1.8,	  2.9,	  3.3) (0.9,	  1.1,	  1.6)
AA,	  augmented	  area;	  MT,	  mineralized	  tissue;	  NMT,	  non-­‐mineralized	  tissue;	  BS,	  bone	  substitute,	  HTaugm	  xmm,	  
horizontal	  thickness	  of	  the	  augmented	  region	  measured	  x	  mm	  apical	  to	  the	  implant	  shoulder;	  HTmucosa	  xmm,	  horizontal	  
thickness	  of	  the	  mucosa	  measured	  x	  mm	  apical	  to	  the	  implant	  shoulder;	  HTtotal	  xmm,	  horizontal	  thickness	  of	  the	  
augmented	  region	  +	  mucosa	  measured	  x	  mm	  apical	  to	  the	  implant	  shoulder;	  SD,	  standard	  deviation;	  Q1,	  first	  
quartile;	  Q3,	  third	  quartile
Parametar Statistical	  analysis*
EB	  vs	  BB EB	  vs	  BG EB	  vs	  C BB	  vs	  BG BB	  vs	  C BG	  vs	  C
AA 0.297 0.148 0.016† 0.578 0.016† 0.039†
MT 0.219 0.461 0.383 0.109 0.078 0.742
NMT 0.688 0.109 0.008† 0.016† 0.016† 0.008†
BS 0.812 0.195 -­‐ 0.078 -­‐ -­‐
HTaugm	  0mm 0.031† 0.063 0.016† 0.250 0.250 0.250
HTaugm	  1mm 0.375 0.383 0.016† 0.750 0.031† 0.063
HTaugm	  2mm 0.578 0.383 0.008† 0.875 0.031† 0.031†
HTaugm	  3mm 0.375 0.461 0.016† 0.578 0.016† 0.063
HTmucosa	  0mm 0.938 0.688 0.047† 0.375 0.047† 0.016†
HTmucosa	  1mm 0.844 0.813 0.688 0.656 0.219 0.848
HTtotal	  0mm 0.156 0.219 0.016† 1.000 0.016† 0.016†
HTtotal	  1mm 0.438 0.813 0.031† 0.313 0.016† 0.063
AA,	  augmented	  area;	  MT,	  mineralized	  tissue;	  NMT,	  non-­‐mineralized	  tissue;	  BS,	  bone	  substitute,	  HTaugm	  
xmm,	  horizontal	  thickness	  of	  the	  augmented	  region	  measured	  x	  mm	  apical	  to	  the	  implant	  shoulder;	  
HTmucosa	  xmm,	  horizontal	  thickness	  of	  the	  mucosa	  measured	  x	  mm	  apical	  to	  the	  implant	  shoulder;	  HTtotal	  
xmm,	  horizontal	  thickness	  of	  the	  augmented	  region	  +	  mucosa	  measured	  x	  mm	  apical	  to	  the	  implant	  
shoulder;	  *,	  results	  of	  repeated	  Wilcoxon	  signed	  rank	  test;	  †,	  statistically	  significant;	  EB,	  equine	  block;	  
BB,	  bovine	  block;	  BG,	  bovine	  granulate;	  C,	  empty	  control
Parametar Unit Treatment	  modality
Equine	  block	  	  (EB)	  
(n=8)
Bovine	  block	  (BB)	  
(n=7)
Bovine	  granules	  (BG)	  
(n=8)
Empty	  control	  (C)	  
(n=8)
Mean	  ±	  SD	  	  	  	  	  	  	  	  	  	  	  	  	  
(Q1,	  median,	  Q3)
AA mm2 19.9	  ±	  5.3 19.5	  ±	  3.0 17.8	  ±	  5.6 11.9	  ±	  2.3
(16.4,	  21.2,	  24.3) (18.2,	  20.6,	  21.6) (12.2,	  18.4,	  22.9) (9.9,	  11.8,	  12.8)
MT mm2 6.0	  ±	  5.5 4.3	  ±	  3.8 5.4	  ±	  2.8 8.9	  ±	  2.5
(2.6,	  2.8,	  7.9) (1.5,	  2.5,	  7.2) (4.4,	  4.6,	  7.2) (6.9,	  8.4,	  10.2)
NMT mm2 11.7	  ±	  6.1 11.8	  ±	  4.6 8.7	  ±	  4.2 3.0	  ±	  0.5
(7.1,	  12.7,	  16.8) (8.2,	  13.9,	  15.0) (4.7,	  8.7,	  12.1) (2.7,	  2.9,	  3.2)
BS mm2 2.1	  ±	  1.6 3.5	  ±	  1.1 3.7	  ±	  1.5 -­‐
(1.0,	  1.7,	  3.8) (3.0,	  3.9,	  4.4) (2.6,	  3.8,	  4.8)
BS-­‐MTsurface % 18.9	  ±	  31.6 16.3	  ±	  21.4 24.4	  ±	  23.0 -­‐
(0.5,	  2.1,	  20.9) (1.7,	  7.8,	  22.4) (8.8,	  18.9,	  29.4)
AA,	  augmented	  area;	  MT,	  mineralized	  tissue;	  NMT,	  non-­‐mineralized	  tissue;	  BS,	  bone	  substitute,	  BS-­‐MTsurface,	  surface	  
fraction	  of	  bone	  substitute	  in	  contact	  with	  mineralized	  tissue;	  SD,	  standard	  deviation;	  Q1,	  first	  quartile;	  Q3,	  third	  
quartile
Parametar Statistical	  analysis*
EB	  vs	  BB EB	  vs	  BG EB	  vs	  C BB	  vs	  BG BB	  vs	  C BG	  vs	  C
AA 1.000 0.313 0.023† 0.578 0.016† 0.078
MT 0.375 0.844 0.148 0.219 0.016† 0.016†
NMT 0.813 0.250 0.008† 0.031† 0.016† 0.016†
BS 0.016† 0.039† -­‐ 0.375 -­‐ -­‐
BS-­‐MTsurface 0.813 0.461 -­‐ 0.016† -­‐ -­‐
AA,	  augmented	  area;	  MT,	  mineralized	  tissue;	  NMT,	  non-­‐mineralized	  tissue;	  BS,	  bone	  substitute,	  BS-­‐
MTsurface,	  surface	  fraction	  of	  bone	  substitute	  in	  contact	  with	  mineralized	  tissue;	  *,	  results	  of	  repeated	  
Wilcoxon	  signed	  rank	  test;	  †,	  statistically	  significant;	  EB,	  equine	  block;	  BB,	  bovine	  block;	  BG,	  bovine	  
granulate;	  C,	  empty	  control
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